Evidence map›Paper›PMID 30284520›Full record

ArticleJournal of applied physiology (Bethesda, Md. : 1985)2018

Transgenic overexpression of active HDAC4 in the heart attenuates cardiac function and exacerbates remodeling in infarcted myocardium.

Ling X Zhang, Jianfeng Du, Yu Tina Zhao, Jianguo Wang, Shouyan Zhang, Patrycja M Dubielecka, Lei Wei, Shougang Zhuang, Gangjian Qin, Y Eugene Chin and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of applied physiology (Bethesda, Md. : 1985), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. Histone Deacetylase 7 protects against pathologic cardiac hypertrophy.Journal of molecular and cellular cardiology · 2026
    Article
  2. Review
  3. Review
  4. Epigenetic regulation of sex dimorphism in cardiovascular health.Canadian journal of physiology and pharmacology · 2024
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Ling X ZhangDepartment of Medicine, Rhode Island Hospital, Brown University , Providence, Rhode Island.
Jianfeng DuDepartment of Surgery, Boston University Medical School, Roger Williams Medical Center , Providence, Rhode Island.
Yu Tina ZhaoDepartment of Surgery, Boston University Medical School, Roger Williams Medical Center , Providence, Rhode Island.
Jianguo WangDepartment of Surgery, Boston University Medical School, Roger Williams Medical Center , Providence, Rhode Island.
Shouyan ZhangDepartment of Cardiology, Luoyang Central Hospital, Zhengzhou University Affiliated Hospital , Luoyang , China.
Patrycja M DubieleckaDepartment of Medicine, Rhode Island Hospital, Brown University , Providence, Rhode Island.
Lei WeiDepartment of Orthopedics, Rhode Island Hospital, Brown University , Providence, Rhode Island.
Shougang ZhuangDepartment of Medicine, Rhode Island Hospital, Brown University , Providence, Rhode Island.
Gangjian QinDepartment of Biomedical Engineering, University of Alabama at Birmingham , Birmingham, Alabama.
Y Eugene ChinKey Laboratory of Stem Cell Biology, Institutes of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences , Shanghai , China.
Ting C ZhaoDepartment of Surgery, Boston University Medical School, Roger Williams Medical Center , Providence, Rhode Island.
Rhode Island Hospital · USProvidence College · USRoger Williams Medical Center · USChinese Academy of Sciences · CNLuoyang Central Hospital Affiliated to Zhengzhou University · CNUniversity of Alabama at Birmingham · US

Funding

Histone Deacetylase Inhibition: A Novel Approach to CardioprotectionR01HL089405 · NHLBI · ROGER WILLIAMS MEDICAL CENTER · PI ZHAO, TING C · 2009 to 2020
$3.4M
p38 acetylation: Novel signaling mechanisms and myocardial protectionR01HL115265 · NHLBI · ROGER WILLIAMS MEDICAL CENTER · PI ZHAO, TING C · 2013 to 2016
$1.6M
NHLBI NIH HHS R01 HL089405NHLBI NIH HHS R01 HL115265
6 · The paper itself

Abstract

Histone deacetylases (HDACs) play a critical role in modulating cardiac function and ischemic injury. HDAC4 was found to be elevated and activated in response to injury. However, whether HDAC4 mediates cardiac function is currently unknown. In this study, we created myocyte-specific activated HDAC4 transgenic mice to examine the role of HDAC4 in mediating cardiac function during development and response to infarction. There are no differences in cardiac function and gross phenotype between wild-type and cardiomyocyte-specific HDAC4 transgenic mice at 1 mo of age. However, cardiac dysfunction and vascular growth deficiency were displayed in 6-mo-old HDAC4-transgenic mice compared with wild-type mice. Activation of HDAC4 increased heart and myocyte size, hypertrophic proteins, and interstitial fibrosis in 6-mo-old mice but not in 1-mo-old mice. To further define whether activated HDAC4 in the heart could impact myocardial function and remodeling, myocardial infarction was created in both wild-type and cardiomyocyte-specific HDAC4-transgenic mice. In myocardial infarction, the overexpression of activated HDAC4 exacerbated cardiac dysfunction and augmented cardiac remodeling and interstitial fibrosis, which was associated with the reduction of cardiokines in the heart. These results indicate the activation of HDAC4 as a crucial regulator for cardiac function in development and myocardial infarction. NEW & NOTEWORTHY We created myocyte-specific activated HDAC4-transgenic mice to examine the function of HDAC4 in mediating cardiac function. HDAC4 overexpression led to cardiac dysfunction, which was associated with increased hypertrophy and myocardial fibrosis. Furthermore, the overexpression of activated HDAC4 exacerbated cardiac dysfunction, augmented remodeling, and increased apoptosis in the infarcted heart. This is the first demonstration that transgenic overexpression of HDAC4 is crucial for modulation of cardiac function and remodeling.

Indexed as

Ventricular RemodelingAnimalsCoronary VesselsFibrosisHeartHistone DeacetylasesHypertrophyMice, TransgenicMyocardial InfarctionMyocardiumMyocytes, CardiacRepressor ProteinsHDAC4 protein, humanHistone DeacetylasesRepressor Proteinscardiac function and injuryhearthistone deacetylase 4

Identifiers

PMID30284520
PMCPMC6737459
OpenAlexW2895264147

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.